$47.35
-0.53 (-1.11%)
Open$47.90
Previous Close$47.88
Day High$48.10
Day Low$45.95
52W High$51.10
52W Low$17.55
Volume—
Avg Volume346.8K
Market Cap2.21B
P/E Ratio—
EPS$-0.54
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-5.0% upside
Current
$47.35
$47.35
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 48.46M | 203.59M | 209.55M |
| Net Income | -51,550,016 | 62.98M | 65.23M |
| Profit Margin | -106.4% | 30.9% | 31.1% |
| EBITDA | -70,337,486 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |